Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:17 PM
Ignite Modification Date:
2025-12-24 @ 10:17 PM
NCT ID:
NCT02849535
Eligibility Criteria:
Inclusion Criteria:
* Patient aged 18 years old or more
* With metastatic renal cell carcinoma
* With an initiation or change of oral targeted therapy, especially: tyrosine kinase inhibitor (sunitinib, sorafenib, pazopanib, axitinib) or mTor inhibitor (everolimus)
* With ambulatory status (not hospitalized for the management and treatment of its metastatic renal cell carcinoma)
* Without either cognitive disorders or major psychiatric disorders
* With a sufficient autonomy for the management of medication at home
* Having declared an outpatient doctor
* Having declared a usual pharmacy
* Having given his written consent to participate in the study
Exclusion Criteria:
* Significant cognitive and psychiatric disorders
* Management of medication at home exclusively performed by the family caregiver
* Patient in an institution or under guardianship, major protected by law
* Patient refusing to participate in the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02849535
Study Brief:
Protocol Section:
NCT02849535